Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Pharmacokinetic considerations in the treatment of multiple sclerosis with interferon-β.
Serum-free spheroid suspension culture maintains mesenchymal stem cell proliferation and differentiation potential.
Factors affecting dignity of patients with multiple sclerosis.
Implanting glass spinal cord windows in adult mice with experimental autoimmune encephalomyelitis.
An adult case of multiphasic disseminated encephalomyelitis manifesting with optic neuritis.
Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.
Gray matter damage predicts the accumulation of disability 13 years later in MS.
EphB3 receptors function as dependence receptors to mediate oligodendrocyte cell death following contusive spinal cord injury.
Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis.
Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis.
Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis.
Expression profiling of the ubiquitin conjugating enzyme UbcM2 in murine brain reveals modest age-dependent decreases in specific neurons.
Lipoprotein-associated lysolipids are differentially involved in high-density lipoprotein- and its oxidized form-induced neurite remodeling in PC12 cells.
Helminth Products Protect against Autoimmunity via Innate Type 2 Cytokines IL-5 and IL-33, Which Promote Eosinophilia.
Decision-making in multiple sclerosis consultations in Italy: third observer and patient assessments.
High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with NMO-IgG.
Abstracts.
Transgenic replacement of Cx32 in gap junction deficient oligodendrocytes rescues the phenotype of a hypomyelinating leukodystrophy model.
Protein-protein interaction analysis highlights additional Loci of interest for multiple sclerosis.
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.
Pupillary response to sparse multifocal stimuli in multiple sclerosis patients.
Minimal clinically important difference for change in comfortable gait speed of adults with pathology: a systematic review.
Severe exacerbation of psoriasis after intravenous immunoglobulin in patient with multiple sclerosis that started during biologic therapy.
Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
Frequency and relevance of IgM intrathecal synthesis in multiple sclerosis.
Pages
« first
‹ previous
…
531
532
533
534
535
536
537
538
539
…
next ›
last »